MRP Capital Investments LLC Has $1.52 Million Stock Holdings in Amedisys, Inc. (NASDAQ:AMED)

MRP Capital Investments LLC trimmed its holdings in shares of Amedisys, Inc. (NASDAQ:AMEDFree Report) by 12.5% in the second quarter, according to its most recent filing with the SEC. The firm owned 16,565 shares of the health services provider’s stock after selling 2,365 shares during the period. Amedisys makes up about 1.4% of MRP Capital Investments LLC’s investment portfolio, making the stock its 21st biggest position. MRP Capital Investments LLC owned 0.05% of Amedisys worth $1,521,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in the business. Allianz Asset Management GmbH boosted its holdings in Amedisys by 146.0% during the fourth quarter. Allianz Asset Management GmbH now owns 39,855 shares of the health services provider’s stock valued at $3,789,000 after purchasing an additional 23,655 shares in the last quarter. Water Island Capital LLC lifted its position in shares of Amedisys by 185.0% during the 4th quarter. Water Island Capital LLC now owns 710,697 shares of the health services provider’s stock worth $67,559,000 after buying an additional 461,368 shares during the period. Nomura Holdings Inc. boosted its stake in Amedisys by 604.2% in the 4th quarter. Nomura Holdings Inc. now owns 49,297 shares of the health services provider’s stock valued at $4,686,000 after buying an additional 42,297 shares in the last quarter. Norges Bank acquired a new stake in Amedisys in the 4th quarter valued at $34,032,000. Finally, SG Americas Securities LLC grew its position in Amedisys by 41.6% in the second quarter. SG Americas Securities LLC now owns 38,315 shares of the health services provider’s stock valued at $3,517,000 after acquiring an additional 11,264 shares during the period. 94.36% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on AMED. Cantor Fitzgerald reissued a “neutral” rating and set a $101.00 price objective on shares of Amedisys in a report on Thursday, July 25th. William Blair downgraded shares of Amedisys from an “outperform” rating to a “market perform” rating in a report on Monday, July 1st. Finally, Deutsche Bank Aktiengesellschaft cut shares of Amedisys from a “buy” rating to a “hold” rating and set a $101.00 price objective on the stock. in a research note on Monday, July 29th. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $100.67.

Read Our Latest Research Report on AMED

Amedisys Stock Performance

Shares of NASDAQ:AMED opened at $97.15 on Thursday. The business has a fifty day moving average of $97.74 and a 200-day moving average of $94.75. The firm has a market cap of $3.17 billion, a PE ratio of -151.80, a price-to-earnings-growth ratio of 1.89 and a beta of 0.78. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.16 and a current ratio of 1.16. Amedisys, Inc. has a twelve month low of $89.55 and a twelve month high of $98.95.

Amedisys (NASDAQ:AMEDGet Free Report) last announced its earnings results on Wednesday, July 24th. The health services provider reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.22 by $0.10. Amedisys had a net margin of 4.02% and a return on equity of 12.39%. The company had revenue of $591.19 million during the quarter, compared to the consensus estimate of $579.34 million. On average, equities research analysts predict that Amedisys, Inc. will post 4.66 EPS for the current fiscal year.

About Amedisys

(Free Report)

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.

Further Reading

Institutional Ownership by Quarter for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.